Intramucosal Implants Market Research Scope Industry Chain Analysis & Opportunities 2018 to 2026

Intramucosal Implants Market.jpg
Intramucosal implants are type of dental implants made with either titanium or zirconium, attached to palatal side of partial or complete denture in mouth region. They require proper thickness of palatal to get attached hence they are inserted in maxilla region of mouth, as it is thick. Intramucosal implants are relatively easy, quick, minimally invasive, and reversible to use.

Intramucosal Implants Market Driver

Use of innovative ideas such as CAD/CAM technology in the field of dentistry is expected to boost growth of the intramucosal’ implants market. For instance, according to the Journal of Interdisciplinary Dentistry 2015, use of Computer Aided Drug Designing (CAD) and Computer Aided Manufacturing (CAM) in the dentistry offers extremely aesthetic, biocompatible intramucosal implants by using materials such as metal alloys, composites, titanium, and polyether ether ketone, and milling machines that restore implants to proper position.

Moreover, increasing use of robotics to assist dentists with procedures such as root canal surgery and orthodontic operations are expected to increase adoption of intramuscular implants. For instance, in September 2017, a robot dentist performed first successful autonomous dental implant surgery by fitting two new teeth into a woman’s mouth in China. The robot was developed by joined collaboration of the Fourth Military Medical University’s affiliated Stomatological Hospital and the Robotic Institute at Beihang University.

Intramucosal Implants Market Restraint

The high cost of intramucosal implants is expected to restrain growth of the market. For instance, according to Dental Associates, in January 2018, the cost for a single implant is US$ 4,817 without bone grafting and US$ 5,557 with bone grafting.

Intramucosal Implants Market – Regional Analysis

On the basis of region, the global intramucosal implants market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

North America is expected to hold dominant position in the global intramucosal implants market, owing to marginal expansions of key players in the dental field. For instance, in July 2018, Danaher Corporation, U.S. based company, announced to expand its dental section into independent, public trading company DentalCo, to maximize dental business innovation in developing implants, services, and solutions to customers.

Asia Pacific is projected to witness significant growth in the intramucosal implants market, owing to increasing awareness regarding use of dental implants through conferences. For instance, in February 2018, Asia Congress of Oral Implantology was held in India to engross educationalists, practitioners and researchers in eminent presentations on the technological, scientific and clinical advancements in the oral implantology sector.

Moreover, in March 2018, Dental Society of Implant Dentistry Center held first Ultra-Short conference specialized in comprehensive dental Implantology on short dental implants in India. Short dental implants allow universal brace positioning and has also been proven bacterially sealed.

Intramucosal Implants Market Competitive Analysis

Key players operating in the global intramucosal implants market include, Institut Straumann AG, Danaher Corporation, Zimmer Biomet Holdings, Inc., Camlog Biotechnologies AG, Osstem Implant Co., Ltd., Avinent Implant System, Biohorizons Iph, Inc., 3M, and Bicon, LLC.

Ask For Discount Before Purchasing This Business Report @ https://www.coherentmarketinsights.com/insight/request-discount/2245

Intramucosal Implants Market – Taxonomy

By Product Type

Titanium Implants
Zirconium Implants

By End Users

Hospitals
Dental Clinics
Others

By Region

North America
Europe
Asia Pacific
Latin America
Middle East
Africa

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.


Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702

Comments

Post a Comment

Popular posts from this blog

Why the Cold Pain Therapy is a Growing Payer Opportunity?

Image
Cold pain therapy is a therapeutic application of cold, used in the treatment of acute soft tissue injuries and to reduce the pain in post-operative condition in orthopedic surgeries, treatment of benign and malignant lesions, and in pain management. Cryotherapy can be applied topically (on the skin surface), surgically or percutaneously. This can also be used to treat various skin conditions such as oral mucositis and tumors in the liver, kidney, bones, breasts and lungs, skin tumors, skin tags, pre-cancerous skin moles, and injuries. Cryosurgery procedure involves use of extreme cold, produced with help of liquid nitrogen (or argon gas) to destroy abnormal tissues. According to the National Cancer Institute (NCI), cryosurgery is used for treatment of several types of cancers and some non-cancerous conditions. It is reported to be effective for treatment in early stage skin cancer, retinoblastoma, actinic keratosis, and cervical intraepithelial neoplasia. Accord...
Read more

Ursodeoxycholic Acid Market Shows Boosted Growth Rate 2018-2026 Estimated by Global Top Players

Image
Ursodeoxycholic acid (UDCA) is a bile acid taken as either a tablet or liquid to treat gallstones and to treat and prevent the progression of cystic fibrosis-related liver disorder. UDCA modifies the bile acid pool by decreasing levels of hydrophobic bile acids while increasing proportion of nontoxic hydrophilic bile acids. UDCA can delay development of gastroesophageal varices and progression to cirrhosis. Moreover it can improve long-term survival in patients with primary biliary cirrhosis. Significant improvement in liver health can be achieved during UDCA therapy in patients with intrahepatic cholestasis of pregnancy, primary sclerosing cholangitis, nonalcoholic fatty liver disease, cystic fibrosis-associated liver disease, total parenteral nutrition-induced cholestasis, graft related liver disease, and in some pediatric cholestatic liver diseases. The global ursodeoxycholic acid market size was valued at US$ 346.2 million in 2017, and is expected to witn...
Read more

Booms and Busts in Anatomic Pathology Market; Dynamics Trends Over The Time Discussed 2018-2026

Image
Anatomic pathology involves direct visualization of human tissue as gross examination as well as under a microscope for proper diagnosis of the disease or a pathological condition. Subtypes of anatomic pathology include surgical pathology, oral and maxillofacial pathology, cytopathology, molecular pathology, and forensic pathology. Procedures performed in anatomic pathology include gross examination, histopathology, immunohistochemistry, in situ hybridization, cryopathology, tissue cytogenetics, and others. Standard approach in anatomical pathology is microscopic examination of tissue samples with the help of one or more stains. Manufacturers have developed stains to identify and classify microorganisms in biopsy of tissue samples or excisional specimens. Various gram stains and acid-fast stains have applications in detection of bacteria and mycobacteria in tissue samples. Commercially available products include tissue processing systems, microtomes, cryostats, ...
Read more